Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study
Abstract Background Hereditary angioedema with C1 inhibitor deficiency is a disabling, potentially fatal condition characterized by recurrent episodes of swelling. Self-treatment is recommended, in order to reduce admissions to the Emergency Room and the time between the onset of the attack and the...
Main Authors: | Andrea Zanichelli, Giulia Maria Azin, Federico Cristina, Romualdo Vacchini, Teresa Caballero |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-018-0797-3 |
Similar Items
-
Hereditary angioedema: Not an allergy
by: Sanjay Bhivgade, et al.
Published: (2012-01-01) -
Anaesthetic management of a patient with hereditary angioedema
by: Nergis Ataol, et al.
Published: (2015-12-01) -
Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
by: N.T.M.L. Fragnan, et al.
Published: (2018-11-01) -
Hereditary angioedema: a disease seldom diagnosed by pediatricians
by: Régis de Albuquerque Campos, et al.
Published: (2021-03-01) -
Hereditary angioedema
by: Helen Lesser, et al.
Published: (2021-07-01)